Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John D. Hainsworth, MD
SCRI Development Innovations, LLC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Gainsville Hematology Oncology Associates
Gainesville, Florida, United States
- Integrated Community Oncology Network
Jacksonville, Florida, United States
- Florida Hospital Cancer Institute
Orlando, Florida, United States
- Wellstar Cancer Research
Marietta, Georgia, United States
- Consultants in Blood Disorders and Cancer
Louisville, Kentucky, United States
- Baton Rouge General Medical Center
Baton Rouge, Louisiana, United States
- Grand Rapids Clinical Oncology Program
Grand Rapids, Michigan, United States
- Methodist Cancer Center
Omaha, Nebraska, United States
- Oncology Hematology Care
Cincinnati, Ohio, United States
- Chattanooga Oncology Hematology Associates
Chattanooga, Tennessee, United States
- Tennessee Oncology, Pllc
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2006
- Primary completion
- 30 Nov 2008
- Completion
- 31 Mar 2011
- Last update posted
- 26 Jul 2013
- Registered enrollment
- 80
- Registry id
- NCT00323739
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.